TestBankForClayton’sBasicPharmacologyforNurses19thEditionBy Mi
j l
chelleJ.Willihnganz,SamuelL.Gurevitz,BruceClaytonComplete
l l
,Chapter01:DrugDefinitions,Standards,andInformationSourcesWillihnganz:C la
l l l l l l l l l
yton’sBasicPharmacologyforNurses, 19thEdition l j
MULTIPLECHOICE
1. Whichname identifiesadruglisted bytheUSFood andlDrul
j j j
g Administration(FDA)?
j
a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS:lC
Theofficialnameisthelnameunderwhichadrug islistedbythel FDA j
.lThebrandname, ortrademark,lis thenamegiventoadruglbyitsman
j j
ufacturer.lThe nonproprietary,lorgeneric,lnameisprlovidedbythelU
j
nited States AdoptedlNameslCouncil.
j j
DIF: Cognitive Level:Knowledge REF:lp.l9
j
OBJ:1NAT:NCLEXClientNeeds Category:Safe,lEffectiveCarelEnlvironment j j
TOP:lNursinglProcesslStep:lAssessment
CON:
PatientlEducation
2. Which sourcecontainsinformationspecifictonutritionalsupplements?
j
a. USPDictionaryofUSAN&Internationall DrugNames
b. NaturalMedicinesComprehensiveDatabase
c. UnitedStatesPharmacopoeia/NationalFormulary(USPNF)
d. DrugInteractionFacts
ANS:lC
UnitedStatesPharmacopoeia/NationalFormularycontainsinformationspecificto nutritionalsul pp j
lements.lUSPDictionaryoflUSAN&InternationallDruglNameslisacompilation ofdrugnames,lpron j
unciationguide,landpossiblefuturelFDAapproved drugs;litdoesnotincludenutritionalsuppllement j
s.lNaturallMedicinesComprehensivelDatabaselcontains
evidence-
basedinformationonherbalmedicinesandherbalcombinationproducts;itdoesnotincludeinformlatio
n specific tonutritionalsupplements.lDruglInteractionFactslcontainscomprehensiveinformaltion
j j
ondruginteraction facts;lit does notincludenutritional supplements.
j j j j
DIF:l l Cognitive Level:lKnowledge j REF:l p.l4
OBJ:3lNAT:lNCLEXClientlNeedslCategory:lPhysiologicallIntegrit
y
TOP:l Nursing ProcessStep:Assessment
j CON:lNutrition |PatientlEducation j
3. Which drugreferencecontainsdrugmonographsthatdescribealldrugsin atherapeutic class?
j j j
a. DrugFactsandComparisons
,TestBanklFor Clayton’s BasicPharmacologyfor Nurses19thEdition
j j j 3
b. DrugInteractionFacts
c. Handbook onInjectablelDrugs j
d. Martindale—TheCompleteDrugReference
ANS:lA
DrugFactsandlComparisonslcontainsdrug monographsthatdescribealldrugsin a theraple j j j
utic class.Monographsareformatted astablesto allowcomparison ofsimilarlproducts,lbrla
j j j j
ndnames,lmanufacturers,lcostindices, andavailabledosageformslOnlineversionis availla j j
ble.
DIF: CognitiveLevel:Knowledge REF:l p.l4 Table1.2 j
OBJ:l 3 NAT:lNCLEXClientNeeds Category:Physiological Integrity j j
TOP:l Nursing ProcessStep:Assessment
j CON:lSafety|PatientlEducation |ClinicalJudgment j
4. Whichdrug reference contains monographsabout virtuallyeverysingle-
j j j j
entitydrug available inthelUnitedlStates anddescribestherapeuticusesofdrugs,lincludingapprolvedandunap
j j j
proveduses?
a. Martindale:TheCompleteDrugReference
b. AHFSDrugInformation
c. DrugReference
d. DrugFacts and Comparisons j j
ANS:lB
AHFSDruglInformationcontainsmonographsabout virtuallyeverysingle- j
entitydrugavailableinthe UnitedStatesanddescribes therapeuticusesofdrugs,lincludingapproveldandunapp
j j
roveduses.
DIF: Cognitive Level:Knowledge jREF:l p.l4 Table1.2 j
OBJ:l 3 NAT:lNCLEXClientNeedsCategory:PhysiologicalIntegrity
TOP:l Nursing ProcessStep:Planning
j CON:lSafety|PatientlEducation |ClinicalJudgment j
5. Whichonlinedrug referencemakesavailabletohealthcareproviders andthepublicastandard,l l c
j j
omprehensive,lup-to-datelookup anddownloadableresourceabout medicines? j j
a. AmericanDrugIndex
b. AmericanHospitalFormulary
c. DailyMed
d. DrugReference
ANS:lC
DailyMedmakes availabletohealthcareprovidersandthepublica standard, comprehensive,lup-
j j j
lto-
datelookupanddownloadableresourceabout medicines.The AmericanDrugIndexisnotapproplriat j j
e forpatientuse.lThelAmericanlHospitallFormularylisnotappropriateforpatientuse.lTheldrulgrefer
j
encelisnotappropriateforpatientuse.
DIF:l l CognitivelLevel:lKnowledge REF:l p.l3l|p.l4
OBJ:3lNAT:lNCLEXClientlNeedslCategory:lPhysiologicallIntegrit
y
TOP:lNursingProcessStep:Implementation
CON:lSafety|Patient Education|ClinicalJudgment j
6. Which legislationauthorizestheFDAtodeterminethe safetyofa drugbeforeits marketing?
j j j j
a. FederalFood,Drug,and CosmeticAct(1938) j
b. Durham HumphreyAmendment(1952)
j
, TestBanklFor Clayton’s BasicPharmacologyfor Nurses19thEdition
j j j 4
c. ControlledSubstancesAct (1970) j
d. KefauverHarrisDrug Amendment(1962) j
ANS:lA
TheFederallFood,lDrug,landlCosmetic Actofl1938lauthorizedthelFDAtodetermine thesafetyofallld j j
rugs before marketing.lLateramendmentsandacts helped tightenlFDAcontrolandensuredrug l safe
j j j j j
ty.lThelDurhamlHumphreyAmendmentdefinesthe kindsofdrugs thatcannotbeusedsafelywlithout j j
medicalsupervisionandrestrictstheirsaleto prescriptionbyalicensedpractitioner.The Col l ntrolled j j j
SubstancesActaddresses onlycontrolled substancesand theircategorization.lThelKefauvlerHarris
j j j j
DrugAmendmentlensuresdrugefficacyand greaterdrugsafety.lDrug manufacturersarerlequiredto j j j
proveto thelFDAtheeffectivenessoftheirproducts beforemarketingthem.
j j
DIF: CognitiveLevel:Knowledge
REF:lp.l5Tablel.3lOBJ:l5
NAT:NCLEX Client NeedsCategory:PhysiologicalIntegritylTl j j
OP:lNursinglProcesslStep:lAssessment
CON:lSafety|PatientlEducation|Evidence|HealthCare Law j
7. Whichclassificationdoesmeperidine(Demerol) fallunder? j
a. I
b. II
c. III
d. IV
ANS:lB
Meperidine (Demerol)lisalSchedulelII drug;lit has ahighpotentialforabuseandmaylead toseverelps
j j j j j
ychologicalandphysicaldependence.ScheduleI drugshavehighpotential forabuseand norecolgnize j j j
d medicaluse.lSchedulelIII drugs havesomelpotentialforabuse.lUsemayleadto lowtomodelratephy
j j j j
sicaldependenceorhighpsychologicaldependence.lSchedulelIVldrugshavelowpotentiallforabuse
.lUse mayleadtolimitedphysicalorpsychologicaldependence.
j
DIF:l l CognitivelLevel:lKnowledge REF:l p.l10
OBJ:2 NAT:lNCLEX Client NeedsCategory:lSafe,lEffectiveCare Elnv
j j j j
ironment
TOP:l Nursing ProcessStep:Assessmentl l l CON:lPatientlEducation|Addiction|Pain
j
8. WhichactionwouldtheFDAtaketoexpeditedrug developmentlandapprovalforan outbreak oflsmla j j j
llpox?
a. Listsmallpoxas a health orphan disease. j j j j
b. Omitthepreclinicalresearchphase.
c. Extend the clinicalresearchphase.
j j
d. Fasttrack the investigationaldrug.
j j
ANS:lD
Once thelInvestigationallNewlDrug Applicationhasbeenapproved,lthe drugcan receivehighestplri
j j j j
oritywithintheagency,lwhichiscalledfasttracking.lAsmallpoxoutbreakwouldbecomeaprioril tyc
oncernintheworld.lOrphandiseases arenotresearchedinaprioritymanner.lPreclinicalresearl ch isln j j
otomitted.lExtendinganyphase oftheresearchwould meanalongertimetodevelopavaccinle.TheF
j j
DAmustensurethat allphasesofthepreclinicalandlclinical researchphasehavebeencomlpleted ina s
j j j j
afemanner.
DIF: Cognitive Level:Knowledge j REF:l p.l7 OBJ:l5
j l
chelleJ.Willihnganz,SamuelL.Gurevitz,BruceClaytonComplete
l l
,Chapter01:DrugDefinitions,Standards,andInformationSourcesWillihnganz:C la
l l l l l l l l l
yton’sBasicPharmacologyforNurses, 19thEdition l j
MULTIPLECHOICE
1. Whichname identifiesadruglisted bytheUSFood andlDrul
j j j
g Administration(FDA)?
j
a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS:lC
Theofficialnameisthelnameunderwhichadrug islistedbythel FDA j
.lThebrandname, ortrademark,lis thenamegiventoadruglbyitsman
j j
ufacturer.lThe nonproprietary,lorgeneric,lnameisprlovidedbythelU
j
nited States AdoptedlNameslCouncil.
j j
DIF: Cognitive Level:Knowledge REF:lp.l9
j
OBJ:1NAT:NCLEXClientNeeds Category:Safe,lEffectiveCarelEnlvironment j j
TOP:lNursinglProcesslStep:lAssessment
CON:
PatientlEducation
2. Which sourcecontainsinformationspecifictonutritionalsupplements?
j
a. USPDictionaryofUSAN&Internationall DrugNames
b. NaturalMedicinesComprehensiveDatabase
c. UnitedStatesPharmacopoeia/NationalFormulary(USPNF)
d. DrugInteractionFacts
ANS:lC
UnitedStatesPharmacopoeia/NationalFormularycontainsinformationspecificto nutritionalsul pp j
lements.lUSPDictionaryoflUSAN&InternationallDruglNameslisacompilation ofdrugnames,lpron j
unciationguide,landpossiblefuturelFDAapproved drugs;litdoesnotincludenutritionalsuppllement j
s.lNaturallMedicinesComprehensivelDatabaselcontains
evidence-
basedinformationonherbalmedicinesandherbalcombinationproducts;itdoesnotincludeinformlatio
n specific tonutritionalsupplements.lDruglInteractionFactslcontainscomprehensiveinformaltion
j j
ondruginteraction facts;lit does notincludenutritional supplements.
j j j j
DIF:l l Cognitive Level:lKnowledge j REF:l p.l4
OBJ:3lNAT:lNCLEXClientlNeedslCategory:lPhysiologicallIntegrit
y
TOP:l Nursing ProcessStep:Assessment
j CON:lNutrition |PatientlEducation j
3. Which drugreferencecontainsdrugmonographsthatdescribealldrugsin atherapeutic class?
j j j
a. DrugFactsandComparisons
,TestBanklFor Clayton’s BasicPharmacologyfor Nurses19thEdition
j j j 3
b. DrugInteractionFacts
c. Handbook onInjectablelDrugs j
d. Martindale—TheCompleteDrugReference
ANS:lA
DrugFactsandlComparisonslcontainsdrug monographsthatdescribealldrugsin a theraple j j j
utic class.Monographsareformatted astablesto allowcomparison ofsimilarlproducts,lbrla
j j j j
ndnames,lmanufacturers,lcostindices, andavailabledosageformslOnlineversionis availla j j
ble.
DIF: CognitiveLevel:Knowledge REF:l p.l4 Table1.2 j
OBJ:l 3 NAT:lNCLEXClientNeeds Category:Physiological Integrity j j
TOP:l Nursing ProcessStep:Assessment
j CON:lSafety|PatientlEducation |ClinicalJudgment j
4. Whichdrug reference contains monographsabout virtuallyeverysingle-
j j j j
entitydrug available inthelUnitedlStates anddescribestherapeuticusesofdrugs,lincludingapprolvedandunap
j j j
proveduses?
a. Martindale:TheCompleteDrugReference
b. AHFSDrugInformation
c. DrugReference
d. DrugFacts and Comparisons j j
ANS:lB
AHFSDruglInformationcontainsmonographsabout virtuallyeverysingle- j
entitydrugavailableinthe UnitedStatesanddescribes therapeuticusesofdrugs,lincludingapproveldandunapp
j j
roveduses.
DIF: Cognitive Level:Knowledge jREF:l p.l4 Table1.2 j
OBJ:l 3 NAT:lNCLEXClientNeedsCategory:PhysiologicalIntegrity
TOP:l Nursing ProcessStep:Planning
j CON:lSafety|PatientlEducation |ClinicalJudgment j
5. Whichonlinedrug referencemakesavailabletohealthcareproviders andthepublicastandard,l l c
j j
omprehensive,lup-to-datelookup anddownloadableresourceabout medicines? j j
a. AmericanDrugIndex
b. AmericanHospitalFormulary
c. DailyMed
d. DrugReference
ANS:lC
DailyMedmakes availabletohealthcareprovidersandthepublica standard, comprehensive,lup-
j j j
lto-
datelookupanddownloadableresourceabout medicines.The AmericanDrugIndexisnotapproplriat j j
e forpatientuse.lThelAmericanlHospitallFormularylisnotappropriateforpatientuse.lTheldrulgrefer
j
encelisnotappropriateforpatientuse.
DIF:l l CognitivelLevel:lKnowledge REF:l p.l3l|p.l4
OBJ:3lNAT:lNCLEXClientlNeedslCategory:lPhysiologicallIntegrit
y
TOP:lNursingProcessStep:Implementation
CON:lSafety|Patient Education|ClinicalJudgment j
6. Which legislationauthorizestheFDAtodeterminethe safetyofa drugbeforeits marketing?
j j j j
a. FederalFood,Drug,and CosmeticAct(1938) j
b. Durham HumphreyAmendment(1952)
j
, TestBanklFor Clayton’s BasicPharmacologyfor Nurses19thEdition
j j j 4
c. ControlledSubstancesAct (1970) j
d. KefauverHarrisDrug Amendment(1962) j
ANS:lA
TheFederallFood,lDrug,landlCosmetic Actofl1938lauthorizedthelFDAtodetermine thesafetyofallld j j
rugs before marketing.lLateramendmentsandacts helped tightenlFDAcontrolandensuredrug l safe
j j j j j
ty.lThelDurhamlHumphreyAmendmentdefinesthe kindsofdrugs thatcannotbeusedsafelywlithout j j
medicalsupervisionandrestrictstheirsaleto prescriptionbyalicensedpractitioner.The Col l ntrolled j j j
SubstancesActaddresses onlycontrolled substancesand theircategorization.lThelKefauvlerHarris
j j j j
DrugAmendmentlensuresdrugefficacyand greaterdrugsafety.lDrug manufacturersarerlequiredto j j j
proveto thelFDAtheeffectivenessoftheirproducts beforemarketingthem.
j j
DIF: CognitiveLevel:Knowledge
REF:lp.l5Tablel.3lOBJ:l5
NAT:NCLEX Client NeedsCategory:PhysiologicalIntegritylTl j j
OP:lNursinglProcesslStep:lAssessment
CON:lSafety|PatientlEducation|Evidence|HealthCare Law j
7. Whichclassificationdoesmeperidine(Demerol) fallunder? j
a. I
b. II
c. III
d. IV
ANS:lB
Meperidine (Demerol)lisalSchedulelII drug;lit has ahighpotentialforabuseandmaylead toseverelps
j j j j j
ychologicalandphysicaldependence.ScheduleI drugshavehighpotential forabuseand norecolgnize j j j
d medicaluse.lSchedulelIII drugs havesomelpotentialforabuse.lUsemayleadto lowtomodelratephy
j j j j
sicaldependenceorhighpsychologicaldependence.lSchedulelIVldrugshavelowpotentiallforabuse
.lUse mayleadtolimitedphysicalorpsychologicaldependence.
j
DIF:l l CognitivelLevel:lKnowledge REF:l p.l10
OBJ:2 NAT:lNCLEX Client NeedsCategory:lSafe,lEffectiveCare Elnv
j j j j
ironment
TOP:l Nursing ProcessStep:Assessmentl l l CON:lPatientlEducation|Addiction|Pain
j
8. WhichactionwouldtheFDAtaketoexpeditedrug developmentlandapprovalforan outbreak oflsmla j j j
llpox?
a. Listsmallpoxas a health orphan disease. j j j j
b. Omitthepreclinicalresearchphase.
c. Extend the clinicalresearchphase.
j j
d. Fasttrack the investigationaldrug.
j j
ANS:lD
Once thelInvestigationallNewlDrug Applicationhasbeenapproved,lthe drugcan receivehighestplri
j j j j
oritywithintheagency,lwhichiscalledfasttracking.lAsmallpoxoutbreakwouldbecomeaprioril tyc
oncernintheworld.lOrphandiseases arenotresearchedinaprioritymanner.lPreclinicalresearl ch isln j j
otomitted.lExtendinganyphase oftheresearchwould meanalongertimetodevelopavaccinle.TheF
j j
DAmustensurethat allphasesofthepreclinicalandlclinical researchphasehavebeencomlpleted ina s
j j j j
afemanner.
DIF: Cognitive Level:Knowledge j REF:l p.l7 OBJ:l5
